1-5 of 5
Fabrizio Marino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial

Andrés J.M. Ferreri, Marianna C. Sassone, Maria Giulia Cangi, Gilda Magliacane, Stefania Zanussi, Elena Flospergher, Fabrizio Marino, Lucia Bongiovanni, Marco Ladetto, Federica Cavallo, Franco Aversa, Antonella Anastasia, Donato Mannina, Anna Pascarella, Daniele Vallisa, Alessandro Pulsoni, Luisella Bonomini, Francesco Bertoni, Riccardo Dolcetti, Emanuele Zucca, Maurilio Ponzoni
Journal: Blood
Blood (2022) 140 (Supplement 1): 6482–6484.
https://doi.org/10.1182/blood-2022-168712
Published: 2022
Journal Articles

Circulating Tumor DNA Integrated with Interim [18F]FDG PET Is Highly Effective in Predicting Outcome of Relapsed/Refractory Classical Hodgkin Lymphoma Treated with the Begev Regimen

Martina Di Trani, Francesca Ricci, Martina Sollini, Eleonora Calabretta, Vanessa Cristaldi, Stefanos Bonovas, Fabrizio Marino, Rita Mazza, Alessio Bruscaggin, Maria Cristina Pirosa, Arturo Chiti, Davide Rossi, Armando Santoro, Carmelo Carlo-Stella
Journal: Blood
Blood (2021) 138 (Supplement 1): 3504.
https://doi.org/10.1182/blood-2021-151362
Published: 2021
Journal Articles

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) with or without Autologous Stem Cell Transplantation (ASCT) As First Line Treatment in Patients with Aggressive B-Cell Lymphoma with MYC and BCL-2 and/or BCL-6 Gene Rearrangements or Increase Copy Number

Alessandra Tucci, MD, Alessandro Re, MD, Chiara Pagani, MD, Anna Guidetti, Anna Dodero, Fabrizio Marino, MD, Ivana Casaroli, MD, Giulia Soverini, MD, Rosa Daffini, MD, Monica Balzarotti, Giulia Campostrini, Luisa Lorenzi, MD, Piera Balzarini, Fabio Facchetti, Carmelo Carlo-Stella, MD, Paolo Corradini, Giuseppe Rossi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-139977
Published: 2020
Journal Articles

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Martina Di Trani, Ettore Rizzo, Silvia Locatelli, PhD, Fabrizio Marino, MD, Vanessa Cristaldi, PhD, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Federica De Paoli, PhD, Giuseppa Careddu, Marcello Rodari, MD, Margarita Kirienko, MD, Eleonora Calabretta, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesca Ricci, MD, Arturo Chiti, MD, Armando Santoro, Stefan Hohaus, MD, Davide Rossi, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 131.
https://doi.org/10.1182/blood-2019-131096
Published: 2019
Journal Articles

Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Treatment in Dual Expressor Diffuse Large B-Cell and Double/Triple Hit Lymphomas: TP53 Mutations Influence on Clinical Outcome

Anna Dodero, MD, Anna Guidetti, MD, Fabrizio Marino, MD, Cristiana Carniti, PhD, Stefania Banfi, Alessandra Tucci, MD, Monica Balzarotti, Antonello Domenico Cabras, MD, Valentina Monti, PhD, Liliana Franca Devizzi, MD, Lucia Farina, MD, Maria Chiara Di Chio, MD, Giuseppe Rossi, Carmelo Carlo-Stella, MD, Paolo Corradini
Journal: Blood
Blood (2019) 134 (Supplement_1): 4116.
https://doi.org/10.1182/blood-2019-124350
Published: 2019